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SuperinfectionIn cattle the interaction between the two genetically and antigenically related bovine lentiviruses, the
acutely pathogenic Jembrana disease virus (JDV) and the non-pathogenic Bovine immunodeﬁciency virus (BIV)
has not been reported although both JDV and a BIV-like virus have been reported in the Bali cattle (Bos
javanicus) population in Indonesia. The outcome of infection of Bali cattle with the R29 strain of BIV prior to
superinfection 42 days later with JDVTAB/87 was determined. All BIV-inoculated cattle were successfully
infected and developed an antibody response to the TM and CA proteins. BIV infection did not prevent
subsequent infection with JDV or ameliorate the clinical signs of Jembrana disease in the infected cattle. It
did, however, modify the dynamics of the JDV infection with an earlier onset and end of the acute disease
process, and a reduction in the duration of viremia that exceeded 106 genome copies/ml of plasma.b),
rdoch.edu.au (R. Dobson),
ail.com (N. Hartaningsih),
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Two bovine lentiviruses have been described, Bovine immunode-
ﬁciency virus (BIV) (Gonda et al., 1987) and Jembrana disease virus
(JDV) (Chadwick et al., 1995a; Kertayadnya et al., 1993), that are
genetically and antigenically related but differ markedly in
pathogenicity.
Antibody to BIV has been detected in several countries (Barboni
et al., 2001; Bhatia et al., 2008; Horzinek et al., 1991; McNab et al.,
1994; Meas et al., 1998; Meas et al., 2000; Suarez et al., 1993; Yesilbag
et al., 2008). It is generally considered non-pathogenic in Bos taurus
(Flaming et al., 1993) although subclinical changes including
lymphocytosis, immune suppression and non-suppurative meningo-
encephalitis have been reported (Carpenter et al., 1992; Munro et al.,
1998; Zhang et al., 1997). In experimentally infected cattle, proviral
DNA was detected in peripheral blood mononuclear cells (PBMC)
from 3 days to 2.5 years and viral RNA in plasma at 6 weeks
(Carpenter et al., 1992) and until 6 months after infection (Wu
et al., 2003). The original BIV-R29 strain (Gonda et al., 1987; Van der
Maaten et al., 1972) is also non-pathogenic in Bali cattle (Bos
javanicus), a domesticated form of wild banteng that is common inIndonesia, with detection of proviral DNA in PBMC from 4 to 60 days
with peak titers 20 days post-infection (dpi) and a transient viremia
from 4 to 14 dpi with a maximum titer of 104 genome copies/ml
plasma (McNab et al., 2010).
JDV has been detected in Indonesia only. It also produces a
subclinical infection in B. taurus (Soeharsono et al., 1995a) but in Bali
cattle, it causes an acute disease 6 to 14 dpi with a case fatality rate of
approximately 17% (Soesanto et al., 1990). The acute disease is
characterized by a marked febrile response, leukopenia and lymph-
adenopathy, a high level viremia with about 108 median infectious
doses (ID50)/ml in blood and pathological changes that reﬂect a
disease affecting the lymphoid system (Dharma et al., 1991;
Soeharsono et al., 1995b). Animals that recover from the acute
disease do not develop any further disease attributable to JDV.
The incidence of clinical Jembrana disease and serological surveys
indicate JDV is common in the Bali cattle population in parts of
Indonesia (Hartaningsih et al., 1993). A BIV-like non-pathogenic
bovine lentivirus is also suspected to occur in the cattle population on
Bali island (Barboni et al., 2001) and antibody to JDV has been
detected in Bali cattle on the island of Sulawesi where there is no
clinical evidence of Jembrana disease in the Bali cattle population
(Desport et al., 2005). Antibody to JDV and BIV cannot be
differentiated due to the presence of numerous cross-reactive
epitopes on the Capsid (CA) (Desport et al., 2005; Kertayadnya
et al., 1993) and Transmembrane (TM) proteins (Burkala et al., 1998).
While the two viruses can be differentiated by PCR techniques (Lew
et al., 2004; Lewis et al., 2009), attempts to detect the putative non-
pathogenic virus present in Indonesia by PCR have been unsuccessful.
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vaccination with inactivated whole virus antigens (Ditcham et al.,
2009). It was considered possible that infection of Bali cattle with a
non-pathogenic BIV-like lentivirus might also induce a protective
immune response against Jembrana disease. Non-pathogenic strains
of other lentiviruses have been shown to induce protective immunity
against pathogenic strains of the same virus. Infection of domestic cats
with non-pathogenic lion lentivirus or puma lentivirus ameliorated
the effects of subsequent wild-type FIV infection (Terwee et al., 2008;
VandeWoude et al., 2002). Similar results were obtained in domestic
cats pre-infected with chimeric FIV (generated by substituting part of
env of clade A FIVPET with a corresponding region of clade B FIVM2, or
vice-versa) and subsequently inoculated with FIVPET or FIVM2
(Giannecchini et al., 2007). Infection of macaques infected with
attenuated SIVmac also ameliorated the effects of challenge with
pathogenic SIVmac (Cranage et al., 1998; Sharpe et al., 2004) and SIVsm
(Nilsson et al., 1998) although attenuated SIVmac did not provide
protection against the more divergent HIV-2 (Nilsson et al., 1998).
We sought to determine whether prior infection of Bali cattle with
the non-pathogenic R-29 strain of BIV would provide protection
against superinfection with pathogenic JDV infection 42 days after the
initial BIV infection.
Results
Clinical and virological observations in cattle after BIV inoculation
Fifteen BIV-inoculated Bali cattle and 4 mock-infected control
cattle were monitored for 42 days and then superinfected with JDV.
During the initial 42 day period after BIV infection, the BIV-infected
cattle did not exhibit any change in rectal temperature or other
clinical signs of disease.
BIV proviral DNA was detected in PBMC initially 7 dpi in one
animal and subsequently in PBMC of all 15 cattle inoculated with BIV,Table 1
BIV proviral DNA detected by PCR in cattle inoculated with BIV and prior to infection
with JDV.
Animal Days after BIV infection
0 7 10 17 19 21 42
Cattle inoculated with BIV at day 0 and then JDV at day 42
CB190 −a − − +a − + −
CB191 − − + + − + −
CB192 − − NT + − + −
CB193 − − NT + + + +
CB194 − − − + + − +
CB195 − − − + + + +
CB196 − − − + + − −
CB197 − − − + − + −
CB205 − − − + + + +
Cattle inoculated with BIV only at day 0
CB198 − − − − − − +
CB199 − + + − + − +
CB200 − − − NTb + − +
CB201 − − + + + − −
CB202 − − − + − − +
CB204 − − + + − − +
Cattle inoculated with JDV only at day 42
CB203 − − NT − − − −
CB206 − − NT − NT − −
CB208 − − − − − − −
CB210 − − − − − − −
Percent BIV-inoculated cattle positive 0 7 15 85 53 47 60
Cumulative % positive 0 7 15 93 93 93 100
Percent mock-inoculated cattle positive 0 0 0 0 0 0 0
a − and + denote negative and positive PCR results, respectively, for BIV proviral
DNA.
b Not tested.conﬁrming that all animals were infected (Table 1). BIV proviral DNA
was detected in most cattle after 17 dpi but at no single time point
was BIV proviral DNA detected concurrently in all 15 cattle. BIV
proviral DNA was not detected in the mock-infected cattle. Plasma
viral RNA was detected in 5 of the 15 cattle in the period from 8 to
13 dpi (Table 2) and plasma viral titers ranged from 1.04 to 4.25 log10
genome copies/ml plasma.
An antibody response to the BIV TMc and CA antigenswas detected
by ELISA (Fig. 1). Antibody to the BIV TMc peptide was detected from
10 dpi and in themajority of cattle by 41 dpi (Fig. 1A). Antibody to the
BIV CA antigenwas detected from 19 dpi (Fig. 1C) but the CA response
was markedly less than the response to the BIV TMc peptide (Fig. 1A).
Only some of the BIV-infected cattle developed CA antibody and only
one seroconverted strongly in the 42 day period after infection. None
of the mock-infected cattle developed BIV TMc or CA antibody
(Figs. 1B and D).Clinical and virological observations after JDV inoculation
Forty two days after BIV infection, 9 of the 15 BIV-infected cattle
and 4 of the mock-infected cattle were inoculated with JDV and
monitored for a further 15 to 19 days. All the JDV-inoculated cattle
developed a febrile response but there were differences in the
response in the previously BIV-infected and non-BIV-infected groups
(Fig. 2). Excluding 2 animals CB190 and CB205 that responded
uncharacteristically to JDV infection and were considered atypical
responders (see below), the febrile response in the BIV-infected group
started 2 days earlier (a mean of 7 dpi compared to 9, P=0.058), the
peak of the febrile response occurred earlier (a mean of 10 dpi versus
12, P=0.067), the peak VL also occurred signiﬁcantly sooner (a mean
of 10 dpi versus 12, P=0.008) and there was a signiﬁcantly earlier
conclusion of the febrile response (a mean of 13 dpi compared to 15,
P=0.033, Table 3). There were no signiﬁcant differences between
groups in regards to the duration and severity of the febrile response
(Table 3). The 6 BIV-only controls did not develop a febrile response or
other clinical signs during the observation period (Fig. 2).
JDV plasma RNA was detected in all cattle inoculated with JDV
from 3 to 19 dpi (Fig. 3). The maximum VL was 2.18×1011 genome
copies/ml plasma. Excluding the two atypical responders, the cattle
infected with JDV, regardless of whether they had been challenged
previously with BIV, developed a viremia typical of that reported
previously (Desport et al., 2009a; Stewart et al., 2005). As shown in
Fig. 3, the pattern and magnitude of the viremia was also similar
between groups, but the viremia started and ﬁnished earlier in the
cattle infected previously with BIV, although these differences were
not statistically signiﬁcant; accordingly, in cattle previously infected
with BIV there was a reduction in the mean duration of the JDV
viremia that was N106 genomes/ml plasma (P=0.068). There were
no signiﬁcant differences between previously BIV-infected and non-
BIV-infected groups in the VL on the ﬁrst or second day of the febrile
period, the peak VL or the total AUC when the viremia was ≥106
genomes/ml plasma (Table 4).
Two animals, CB190 and CB205, responded atypically to JDV
infection. The cattle had a late onset fever (Fig. 2 and Table 3) and the
dynamics of their viremia were different to those in the other cattle
(Fig. 3), similar to an atypical responder previously reported (Desport
et al., 2009a). These animals had an erratic viremia increasing to a
maximum titer of approximately 1010 genome copies/ml which
continued through to the conclusion of the experiment. As the viremia
in these animals did not decrease before the experiment concluded,
the data provided for the duration of the viremia provided in Table 4 is
an underestimate of the actual values.
After inoculation with JDV, plasma BIV RNA was again detected in
4 of the 9 superinfected cattle (Table 2). The titer of BIV RNA during
this period ranged from 1.40 to 2.57 log10 genome copies/ml plasma.
Table 2
BIV viral RNA genome copies/ml of plasma determined by qPCR in cattle inoculated with BIV at day 0 (all cattle) and JDV at day 42 (CB190–CB205 only).
Animal Days after BIV inoculation Days after JDV inoculation
0–1a 7 8 9 10 11 13 14–42d 44–50e 51 52 53 54 55 56–63f
Cattle inoculated with BIV at day 0 and JDV at day 42
CB190 −b − − − 1.20c − 4.25 − − − − − − − −
CB191 − − − − − − 1.89 − − 1.40 − − − − −
CB192 − − − − − − − − − − − − − − −
CB193 − − − − 1.79 − − − − − − − − − −
CB194 − − − − − − − − − − − 1.86 − − −
CB195 − − − − − − − − − 2.18 − 2.57 2.51 1.48 −
CB196 − − − − − − − − − − − − − − −
CB197 − − − − − − − − − 1.79 − − − − −
CB205 − − 1.04 2.45 − − − − − − − − − − −
Cattle inoculated with BIV at day 0 only
CB198 − − − − − − − − − − − − − − −
CB199 − − − − − − − − − − − − − − −
CB200 − − − − − − − − − − − − − − −
CB201 − − − − − − − − − − − − − − −
CB202 − − − − − − − − − − − − − − −
CB204 − − − 1.04 − − − − − − − − − − −
a Represent results from 0 and 1 dpi.
b Negative.
c Genome copies/ml plasma (log10).
d Represents results from 14–17, 19, 21, 28, 35 and 41–42 dpi.
e Represents results from 44, 46 and 48–50 dpi.
f Represents results from 56–59, 61 and 63 dpi.
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15 day period after JDV infection in a majority of cattle previously
infected with BIV (Fig. 4A) but was not detected in any of the JDV-
infected cattle that had not been infected previously with BIVFig. 1. TMc and CA IgG response in serum of cattle after inoculation with BIV, shown as box
peptide in all 15 cattle inoculated with BIV at day 0. (B) Response detected by BIV TMc pepti
antigen in all 15 cattle inoculated with BIV at day 0. (D) Response detected by His-BIV CA a(Fig. 4B). ELISA absorbances to the CA protein increased at 4 days
after JDV infection in the cattle that had been previously infected with
BIV (Fig. 4D). BIV CA ELISA absorbances remained low in the cattle
infected with JDV only (Fig. 4F).and whisker plots of the ELISA absorbance values. (A) Response detected by BIV TMc
de antigen in all 8 cattle mock inoculated at day 0. (C) Response detected by His-BIV CA
ntigen in all 8 cattle mock inoculated at day 0.
Fig. 2. Mean rectal temperatures in cattle inoculated with JDV. Y-error bars represent
the standard deviations of rectal temperatures. Shown are the rectal temperatures in
JDV-only control cattle ( ; CB203, CB206, CB208 and CB210), in cattle which had been
previously inoculated with BIV and responded to JDV in a typical fashion ( ; CB191–
CB197), in cattle which had been previously infected with BIV and responded to JDV in
an atypical fashion ( ; CB190 and CB205) and in cattle infected previously with BIV but
not infected with JDV (■).
Fig. 3. Mean plasma viral loads (JDV RNA genome copies/ml plasma) in animals
inoculated with JDV at day 0. Y-error bars represent the standard deviations of viral
loads. Shown are viral loads in JDV-only control cattle ( ; CB203, CB206, CB208 and
CB210), cattle which had been previously infected with BIV and responded to JDV in a
typical fashion ( ; CB191–CB197) and cattle which had been previously infected with
BIV and responded to JDV in an atypical fashion ( ; CB190 and CB205).
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Under the conditionswithwhich theexperimentwas conducted, prior
BIV infection did not prevent subsequent JDV infection or result in
signiﬁcant amelioration of the normal response of Bali cattle to JDV
infection. A case fatality rate of about 20% is normally evident in JDV-
infected Bali cattle (Desport et al., 2009a) but no fatalities occurred in any
of the JDV-infected cattle during the 14 day observation period after
infection so no effect on the JDV-associated case fatality rate of prior BIV
infection was determined.
Although it did not alter the normal clinical response to JDV infection,
prior infection of cattle with BIV resulted in an earlier onset of Jembrana
disease. Although some of the effects were not signiﬁcantly different,
cattle previously infected with BIV developed an earlier onset of fever, an
earlier peak febrile response, a signiﬁcantly earlier peak viral load and a
signiﬁcantly earlier resolution of fever following superinfection with JDVTable 3
Effect of previous BIV infection of cattle on the febrile response following JDV infection.
Animal Days after infection
Peak VL Onset of febrile response Peak febrile respons
Cattle infected with BIV 42 days previously
CB190 18 17 18
CB191 8 5 8
CB192 9 8 10
CB193 12 11 13
CB194 9 4 10
CB195 11 8 10
CB196 9 7 10
CB197 9 7 9
CB205 18 17 20
Mean 11 (10)a 9 (7)a 12 (10)a
Variance 15.28 22.75 17.75
Cattle not previously infected with BIV
CB203 12 8 10
CB206 12 10 13
CB208 11 10 11
CB210 12 9 12
Mean 12 9 12
Variance 0.25 0.92 1.67
P-valueb 0.441 (0.008)c 0.487 (0.058)c 0.412 (0.067)c
a Mean calculated excluding atypical responders.
b P-values represent statistical differences between animals infected with BIV and then J
c P-value calculated excluding atypical responders CB190 and CB205.(Table 3). There were no effects on the dynamics of the viral load except
for a reduction in the duration of the viremia that exceeded 106 genome
copies/ml of plasma (Table 4). The lack of statistical signiﬁcance in those
animals that responded typically was probably at least partly due to the
wide variance in the response to JDV of the cattle previously infectedwith
BIV.
The enhanced early replication of a superinfecting virus seen here has
not been reported previously in superinfections with other related
lentiviruses. An earlier onset of disease has, however, been reported with
Caprine arthritis encephalitis virus (CAEV) following vaccination. Goats
vaccinated with inactivated CAEV developed arthritis more rapidly after
CAEV infection than control animals (McGuire et al., 1986). Horses
vaccinated with a recombinant and Equine infectious anemia virus (EIAV)
subunit vaccine and then challenged with EIAV displayed severe
enhancement of viral infection and exacerbation of disease (Montelaro
et al., 1996). JDV has recently been identiﬁed as replicating in IgG-
containing cells (Desport et al., 2009b) and the earlier replication of JDV in
BIV-infected cattle may be due to the B cell stimulatory activity of BIVDuration of febrile response (days)
e End of febrile response Low Moderate High Total
21 1 3 0 4
13 4 2 2 8
12 3 1 0 4
16 4 1 0 5
12 8 0 0 8
15 3 3 1 7
12 1 3 1 5
13 3 3 0 6
21 0 3 1 4
15 (13)a 3 2 1 6
13.50 5.50 1.36 0.53 2.75
15 2 5 0 7
15 4 1 0 5
14 1 2 1 4
17 4 4 0 8
15 3 3 0 6
1.58 2.25 3.33 0.25 3.33
0.449 (0.033)c 0.425 0.153 0.233 0.376
DV and those infected with JDV only.
Table 4
Effect of previous BIV infection on the dynamics of the JDV viral load (VL) in plasma
after JDV inoculation.
Animal VL 1st day of
febrile period
(log10)










Cattle infected with BIV 42 days previously
CB190 6.61 9.77 11.34 10.15 5.60
CB191 7.35 10.63 10.12 11.76 11.20
CB192 8.49 9.59 9.59 9.71 7.40
CB193 8.89 9.26 9.26 9.68 8.60
CB194 1.91 4.64 9.98 10.25 7.60
CB195 9.23 10.12 10.57 10.98 10.10
CB196 9.22 9.25 10.31 10.44 9.60
CB197 9.36 9.93 10.72 11.00 8.50
CB205 11.25 10.68 10.68 10.70 9.20
Mean 8.04 9.06 10.08 10.55 9.00
Variance 7.001 4.045 0.270 0.570 1.917
Cattle not previously infected with BIV
CB203 9.98 10.28 10.73 11.18 16.40
CB206 9.40 10.01 10.18 10.55 10.30
CB208 7.54 8.95 10.02 10.22 10.70
CB210 7.46 9.16 10.13 10.60 13.40
Mean 8.59 9.60 10.26 10.64 12.53
Variance 1.655 0.417 0.100 0.158 7.776
P-valuea 0.624 0.692 0.931 0.404 0.068
a P-values represent statistical differences between groups of animals infected with
BIV 42 days prior to infection with JDV and those infected with JDV only.
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suppression (Zhang et al., 1997) and it is possible that the earlier onset of
disease in animals with prior BIV infection is due to this.
The lack of amelioration of the febrile response and the replication
of JDV in the cattle previously infected with BIV occurred despite a
strong antibody response to the BIV TM and, in a proportion of the
cattle, an antibody response to the CA at the time of JDV inoculation.
Due to the close antigenic relationship between JDV and BIV (Desport
et al., 2005; Kertayadnya et al., 1993) the result was not expected as
other lentiviruses have been shown to offer protection against
infection with closely related heterologous viruses. Domestic cats
infected with non-pathogenic puma or lion lentiviruses developed
humoral and cell-mediated immune responses against both homol-
ogous and heterologous FIV isolated from domestic cats (Vande-
Woude et al., 2003) and suppressed FIV-induced CD4+ T-cell
depletion (Terwee et al., 2008; VandeWoude et al., 2002) and FIV-
induced plasma and PBMC viral loads (VandeWoude et al., 2002).
Domestic cats pre-infected with a chimeric FIV and subsequently
infected with fully virulent FIV ameliorated the clinical effects of the
virulent challenge virus in some challenged cats, and reduced viral
RNA and proviral DNA loads in others (Giannecchini et al., 2007).
It has been suggested that the R29 strain of BIV may have become
attenuated since its isolation in 1969 (Van der Maaten et al., 1972) and
prolonged storage and passage in cell culture (Whetstone et al., 1997) as
the disease induced experimentally with the virus does not resemble the
lesions seen in the animal fromwhich itwasﬁrst isolated. Anunsuccessful
attempt was made to increase the virulence of BIV-R29 by its serial
passage through cattle (Whetstone et al., 1990), a technique known to
increase the virulence of EIAV (Orrego et al., 1982), and perhaps this
inability to increase its virulence reﬂects a natural low pathogenicity.
Other BIV strains isolated from Florida were thought to be more
pathogenic thanBIV-R29, causingaBcell lymphocytosis inexperimentally
infected cattle, but the effects of the Florida isolates in cattlewere still very
mild (Suarez et al., 1993; Whetstone et al., 1997).
It is also possible that the 42 day period between BIV infection and
subsequent JDV infection was too short for an effective protective
immunity to develop. Although there was a strong antibody response
to the TM protein of BIV at the time of JDV infection, and a anamnesticantibody response to TM and CA after JDV infection, which is normally
delayed until at least 6 weeks after infection (Hartaningsih et al.,
1994), this response may be unrelated to the development of a
protective immune response which may require a longer period to
develop with the bovine lentiviruses. However, protection against SIV
in macaques could be achieved within 21 days of infection with a live
attenuated SIV, with partial protection against wild-type SIV provided
within 10 days of inoculation (Stebbings et al., 2004).
The dose of BIV used for infection and the challenge dose of JDV may
also be factors responsible for lack of resistance to JDV infection following
BIV infection. Studies of SIVmac in macaques have shown that the dose of
primary virus affects the level of resistance to infectionwith a pathogenic
virus (Cranage et al., 1998). Macaques given higher doses, 2000–20000
TCID50, of SIVmacC8were shown to completely resist infectionwith SIVmac,
shown by a lack of virus detection by PCR and a lack of virus isolation,
whereas animals given lower doses of primary virus, 2–200 TCID50, were
protected against a loss of CD4 cells only.
While there was no evidence that prior BIV infection provided
protection against the pathological effects of subsequent JDV infection,
there was also no evidence that the prior BIV infection exacerbated
subsequent JDV infection, as reported in cases of HIV superinfection.
Epidemiological observations suggest that infection with a second
heterologous strain of HIV-1 has in the majority of cases, accelerated
disease progression after infection, reviewed previously (Smith et al.,
2005). It was observed in the current experiments that JDV infection in
cattle previously infected with BIV reactivated replication of the BIV, and
this appears to be an observation seen during heterologous lentivirus
infections. Reactivation of primary infection virus has also been seen in
HIV-2 infected macaques superinfected with SIVmac (Petry et al., 1995)
and in HIV-2 infected baboons superinfected with heterologous HIV-2
(Locher et al., 1997). Reactivation might be associated with the potent
transactivation function of the JDV Tat protein, which was shown to be a
potent transactivator not only of its own long terminal repeat (LTR) but
also the BIV andHIV-LTR in vitro (Chen et al., 2000; Chen et al., 1999). JDV
Tat may function similarly in vivo in Bali cattle.
There is no evidence of the outcome of mixed infections with JDV and
non-pathogenic BIV-like viruses under ﬁeld situations in the Bali cattle
population of Indonesia. Althoughmixed infectionwith JDV and a second
BIV-like virus has been reported to occur in Bali cattle on Bali island
(Barboni et al., 2001), the difﬁculty of detecting BIV-like virus in cattle and
the close antigenic relationship of the two viruses has so far precluded the
epidemiological study of mixed infection by JDV and possible non-
pathogenic BIV-like viruses. BIV proviral DNA is only transiently present
within PBMC of experimentally infected Bali cattle (McNab et al., 2010)




Nineteen cattle approximately 18 months of age were obtained
from Nusa Penida, an island adjacent to Bali where Jembrana disease
has never been detected and the cattle have been consistently
negative to antibody to JDV and BIV (Hartaningsih et al., 1993). The
cattle were housed indoors as previously described (Soeharsono et al.,
1990). Cattle were screened by PCR and ELISA to ensure they were not
infected with bovine lentiviruses prior to challenge (Lewis et al.,
2009). Six weeks prior to infectionwith BIV the cattle were vaccinated
against Bovine viral diarrhea virus with Pestigard® (Pﬁzer).
Viruses
BIV-R29 for infection of cattle was obtained from J Brownlie and M
Collins, Royal Veterinary College, UK. The virus was cultured in primary
bovine fetal lung (BFL) cells and titrated in BFL cells as previously
Fig. 4. IgG response detected by JDV TMc peptide and His-BIV CA after inoculation with JDV, shown as box andwhisker plots of the ELISA absorbance values. (A) Response detected by
JDV TMc peptide in cattle infected with JDV at day 0 and infected with BIV 42 days earlier. (B) Response detected by JDV TMc peptide in cattle infected with JDV at day 0 but not
infected previously with BIV. (C) Response detected by JDV TMc peptide in cattle not infected with JDV at day 0 but infected with BIV 42 days earlier. (D) Response detected by His-
BIV CA in cattle infected with JDV at day 0 and infected with BIV 42 days earlier. (E) Response detected by His-BIV CA in cattle infected with JDV at day 0 only. (F) Response detected
by His-BIV CA in cattle not infected with JDV at day 0 but infected with BIV 42 days earlier.
266 T. McNab et al. / Virology 404 (2010) 261–268described (McNab et al., 2010). An estimated 1.82×104 50% tissue culture
infectious doseswas inoculated into each animal, half subcutaneously and
half intravenously.
JDVTAB/87 (Chadwick et al., 1995b) for infection of cattle was prepared
by infectionof antibody-negative cattlewith a suspensionof frozen spleen
harvested from infected cattle as described previously (Soeharsono et al.,
1990). Plasma from the infected cattle was obtained 2 days after the
development of a febrile response typical of Jembrana disease, and the
approximate ID50 in the plasma determined using an antigen-capture
ELISA as described previously (Stewart et al., 2005). An estimated 1000
ID50 of the virus was inoculated intravenously into each animal.Experimental infection and sampling of cattle
Nine cattle were inoculated with BIV at day 0 andwith JDV 42 days
later (CB190–CB197 and CB205). Six cattle were inoculated with BIV
at day 0 and were not subsequently inoculated with JDV (CB198–CB202 and CB204). Four cattle were inoculated with uninfected BFL
cells in RPMI medium at day 0 and subsequently with JDV 42 days
later (CB203, CB206, CB208 and CB210).
Animals were observed daily for clinical signs of disease. Rectal
temperatures were measured daily for the duration of the study.
Heparinized blood samples were obtained as required by venipuncture
of the jugular vein and used for extraction of DNA from PBMC, extraction
of RNA from plasma and serum for serological tests.Extraction of DNA and RNA from peripheral blood
PBMC were puriﬁed from 10ml of heparinized blood using a Ficoll-
Paque PlusTM (GE Healthcare) gradient as recommended by the
manufacturer. DNA was extracted from the PBMC using a QIAamp DNA
Mini Kit (Qiagen) as recommended by the manufacturer. Viral RNA was
extracted from plasma using the QIAamp Viral RNA Extraction Kit
(Qiagen) as recommended by the manufacturer.
267T. McNab et al. / Virology 404 (2010) 261–268Detection of BIV proviral DNA
The integrity of genomic DNA was conﬁrmed using gene-speciﬁc
glyceraldehyde-3-phosphate dehydrogenase primers as previously
described (McNab et al., 2010). BIV proviral DNA loads were
determined using a conventional PCR assay as described previously
(McNab et al., 2010).
Quantiﬁcation of BIV and JDV RNA in plasma
BIV RNA was quantiﬁed as described by McNab et al. (2010) and
JDV RNA as described by Stewart et al. (2005), with the following
exceptions: 1× RT-PCR Reaction Mix for Probes (Bio-Rad), 0.2 μl
iScript Reverse Transcriptase for One-Step RT-PCR (Bio-Rad) and 2 μl
RNA extracted from plasma was added to each reaction. The reaction
was made up to 10 μl using nuclease free water (Bio-Rad).
ELISA
The BIV TM antibody response was determined by ELISA using a
cyclic BIV TM (BIV TMc) peptide as described previously (McNab et al.,
2010). The JDV TM antibody response was determined by ELISA using
a cyclic JDV TM (JDV TMc) peptide as previously described (Ditcham
et al., 2009) as while there was extensive cross-reactivity between
JDV and BIV TM antigens, our experience was that the JDV TMc
peptide provided greater sensitivity in the detection of JDV TM
antibody than did the BIV TMc antigen. The BIV CA antibody response
was determined using an ELISA with a recombinant BIV CA antigen as
previously described (McNab et al., 2010) except that 100 ng of
protein was coated onto each well and serum was tested at a dilution
of 1:100.
Analysis of data
To determine whether prior BIV infection would induce protection
against subsequent JDV infection, differences between the viral load
(VL) on the ﬁrst and second day of the febrile period when the rectal
temperature exceeded 39.3 °C, the peak VL, the duration and
magnitude of the VL where the area under the curve (AUC)
was N106 genomes/ml, and the duration of the febrile period, were
compared in JDV-infected cattle that had been previously infected
with BIV and in cattle not previously infectedwith BIV, as described by
(Desport et al., 2009a; Ditcham et al., 2009). The AUC where the VL
was N 106 for each animal was estimated and linear interpolation
between consecutive observations, in combination with the previ-
ously described piecewise-linear model was used to supply missing
data caused by sampling intervals (Ditcham et al., 2009). The duration
of the infectious period was deﬁned as the period where VL was N106
genomes/ml. A baseline of 106 was chosen (Ditcham et al., 2009) as
bloodmeal residues of between 4 and 10 nl have been reported on the
mouthparts of tabanid ﬂies and EIAV at 106 ID/ml in blood can be
transmitted by a single ﬂy (Foil et al., 1987). For analysis of the febrile
response, rectal temperatures were divided into ranges adapted from
a previously described method (Muraguri et al., 1999) as low fever
(N39.3 °C–40.2 °C), moderate fever (40.3 °C–41.2 °C) and high fever
(N41.2 °C). Student's t-test was used for statistical comparison of the
magnitude and duration of plasma VL and febrile responses and P-
valuesb0.05 were considered statistically signiﬁcant.
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